Inhibitory role for GABA in autoimmune inflammation.
Roopa Bhat1, Robert Axtell, Ananya Mitra
1Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University, Stanford, CA 94305, USA. roopa.bhat@stanford.edu
Summary
Gamma-aminobutyric acid (GABA) plays an inhibitory role in both the brain and immune system. Enhancing GABAergic activity ameliorates experimental autoimmune encephalomyelitis (EAE) by reducing inflammation.
Area of Science:
- Neuroimmunology
- Molecular Neuroscience
Background:
- Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system.
- Emerging evidence suggests GABA also influences immune system function.
Purpose of the Study:
- To investigate the role of GABA signaling in immune cells.
- To determine if manipulating the GABA pathway impacts experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis.
Main Methods:
- Assessed GABA synthesis and catabolism machinery in immune cells.
- Examined expression and function of GABA receptors on antigen-presenting cells (APCs).
- Evaluated the therapeutic potential of GABAergic agents in an EAE mouse model.
Main Results:
- Immune cells possess the machinery for GABA synthesis, catabolism, and signaling.
- APCs express functional GABA receptors and respond to GABA.
- Increased GABAergic activity significantly reduced paralysis and inflammation in EAE mice.
- GABAergic agents directly inhibited MAPK signaling in APCs, dampening adaptive immune responses to myelin proteins.
Conclusions:
- The immune system is equipped for GABA signaling, with GABA acting as a potential paracrine or autocrine factor.
- Targeting the GABA pathway offers a promising therapeutic strategy for neuroinflammatory diseases like multiple sclerosis by modulating immune cell activity.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...